Il y a eu 50 transactions d'initiés récentes enregistrées pour Arcellx, Inc. (ACLX), dont 11 achats et 34 ventes. Le total des achats d'initiés s'élève à $5.5M et le total des ventes d'initiés à $55.44M.
Les initiés notables ayant une activité récente comprennent Gilson Michelle, Elghandour Rami, Lubner David Charles. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ACLX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-17 |
Gilson Michelle |
Chief Financial Officer |
Don (Donné) |
5,000 |
- |
- |
28,938 |
| 2026-03-04 |
Elghandour Rami |
See Remarks |
Don (Donné) |
101,164 |
- |
- |
174,887 |
| 2026-02-27 |
Elghandour Rami |
See Remarks |
Vente Informative |
89,916 |
$113.92 |
$10.24M |
276,051 |
| 2026-02-25 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
11,219 |
$113.82 |
$1.28M |
33,938 |
| 2026-02-19 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
100 |
$69.38 |
$6.94K |
45,157 |
| 2026-02-17 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
4,150 |
$70.01 |
$290.55K |
53,541 |
| 2026-02-11 |
Elghandour Rami |
See Remarks |
Don (Donné) |
218,500 |
- |
- |
563,967 |
| 2026-01-20 |
Lubner David Charles |
Director |
Vente Informative |
6,000 |
$75.00 |
$450K |
21,659 |
| 2026-01-14 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
5,882 |
$68.51 |
$403K |
23,749 |
| 2026-01-13 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
7,437 |
$65.51 |
$487.21K |
29,631 |
| 2026-01-12 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
6,131 |
$64.15 |
$393.29K |
37,068 |
| 2026-01-06 |
Elghandour Rami |
See Remarks |
Exercice d'Options (Vente) |
55,991 |
- |
- |
167,973 |
| 2026-01-06 |
Heery Christopher |
Chief Medical Officer |
Exercice d'Options (Vente) |
13,064 |
- |
- |
39,194 |
| 2026-01-06 |
Gilson Michelle |
Chief Financial Officer |
Exercice d'Options (Vente) |
20,530 |
- |
- |
61,590 |
| 2026-01-03 |
Elghandour Rami |
See Remarks |
Exercice d'Options (Vente) |
53,098 |
- |
- |
- |
| 2026-01-03 |
Heery Christopher |
Chief Medical Officer |
Exercice d'Options (Vente) |
16,520 |
- |
- |
- |
| 2026-01-03 |
Gilson Michelle |
Chief Financial Officer |
Exercice d'Options (Vente) |
15,340 |
- |
- |
- |
| 2026-01-02 |
Elghandour Rami |
See Remarks |
Exercice d'Options (Vente) |
55,459 |
- |
- |
55,459 |
| 2026-01-02 |
Heery Christopher |
Chief Medical Officer |
Exercice d'Options (Vente) |
13,021 |
- |
- |
13,021 |
| 2026-01-02 |
Gilson Michelle |
Chief Financial Officer |
Exercice d'Options (Vente) |
20,496 |
- |
- |
20,496 |
| 2025-11-17 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
340 |
$90.00 |
$30.6K |
284 |
| 2025-10-15 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
5,364 |
$91.04 |
$488.32K |
8,466 |
| 2025-10-06 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
1,064 |
$86.22 |
$91.73K |
13,830 |
| 2025-10-03 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
4,882 |
$86.00 |
$419.87K |
14,894 |
| 2025-09-30 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
1,530 |
$82.20 |
$125.76K |
624 |
| 2025-09-29 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
73 |
$80.16 |
$5.85K |
21,658 |
| 2025-09-26 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
12,396 |
$80.12 |
$993.16K |
21,731 |
| 2025-09-19 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
300 |
$80.00 |
$24K |
34,127 |
| 2025-09-18 |
Heery Christopher |
Chief Medical Officer |
Vente Informative |
3,343 |
$80.01 |
$267.47K |
34,427 |
| 2025-08-28 |
Elghandour Rami |
See Remarks |
Retenue Fiscale RSU |
546,938 |
$70.25 |
$38.42M |
617,919 |
| 2025-08-12 |
Behbahani Ali |
Director |
Autre (Achat) |
1,586 |
- |
- |
1,925 |
| 2025-06-10 |
Patel Kavita |
Director |
Vente Informative |
1,500 |
$67.36 |
$101.04K |
- |
| 2025-05-29 |
Galligan Andrew H |
Director |
Attribution de RSU |
1,784 |
$63.68 |
$113.61K |
1,784 |
| 2025-05-29 |
Lubner David Charles |
Director |
Attribution de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Carroll Jill |
Director |
Attribution de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Behbahani Ali |
Director |
Attribution de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Ware Olivia C |
Director |
Attribution de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Patel Kavita |
Director |
Attribution de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Myers Kristin |
Director |
Attribution de RSU |
1,784 |
$63.68 |
$113.61K |
1,784 |
| 2025-05-27 |
Gilson Michelle |
Chief Financial Officer |
Vente Informative |
8,449 |
$64.38 |
$543.91K |
19,776 |
| 2025-05-23 |
Gilson Michelle |
Chief Financial Officer |
Exercice d'Options (Vente) |
22,429 |
- |
- |
- |
| 2025-05-20 |
Patel Kavita |
Director |
Vente Informative |
1,500 |
$58.43 |
$87.65K |
- |
| 2025-04-29 |
Patel Kavita |
Director |
Vente Informative |
1,500 |
$64.20 |
$96.3K |
- |
| 2025-04-08 |
Patel Kavita |
Director |
Vente Informative |
1,500 |
$57.50 |
$86.25K |
- |
| 2025-03-18 |
Patel Kavita |
Director |
Vente Informative |
1,500 |
$71.64 |
$107.46K |
- |
| 2025-03-18 |
Galligan Andrew H |
Director |
Inconnu |
- |
- |
- |
5,000 |
| 2025-03-18 |
Galligan Andrew H |
Director |
Attribution de RSU |
16,829 |
$69.87 |
$1.18M |
16,829 |
| 2025-03-18 |
Myers Kristin |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-18 |
Myers Kristin |
Director |
Attribution de RSU |
16,829 |
$69.87 |
$1.18M |
16,829 |
| 2025-02-27 |
Elghandour Rami |
See Remarks |
Attribution de RSU |
668,416 |
- |
- |
817,602 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
